Acrivon Therapeutics, Inc. — SC 13G/A Filings
10 SC 13G/A filings on record
This page lists all SC 13G/A filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 10 SC 13G/A documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G/A | AMENDMENT NO. 2 TO SCHEDULE 13G | 0001213900-24-060604 | Jul 10, 2024 | — |
| SC 13G/A | AMENDMENT NO. 1 TO SCHEDULE 13G | 0001213900-24-060601 | Jul 10, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-095564 | Apr 15, 2024 | — |
| SC 13G/A | SC 13G/A | 0001104659-24-023918 | Feb 14, 2024 | — |
| SC 13G/A | SC 13G/A | 0001193125-24-036370 | Feb 14, 2024 | — |
| SC 13G/A | ACRIVON THERAPEUTICS, INC. | 0000902664-24-001626 | Feb 14, 2024 | — |
| SC 13G/A | — | 0000908834-24-000055 | Feb 13, 2024 | — |
| SC 13G/A | — | 0001175707-23-000086 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001193125-23-038734 | Feb 14, 2023 | — |
| SC 13G/A | SC 13G/A | 0001104659-23-020729 | Feb 14, 2023 | — |